Led by NYU researcher Michael Bogenschutz, this Phase 2 study on psilocybin for alcohol use disorder is showing promising results and paves the way for a larger study to seek approval by the FDA for treating alcohol use disorder with psilocybin.
#psilocybin #alcoholism #addiction
00:00 Overview
00:37 Treatment for Alcohol Use Disorder
01:13 Magic Mushrooms
02:43 The Study
03:24 The Future
Dan’s website
https://www.inclusionrecovery.com
The Study: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2795625?guestAccessKey=ab1fc0a8-8930-47b3-9d4b-831ee984c884&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082422
Additional Sources
https://www.fda.gov/patients/clinical-trials-what-patients-need-know/what-are-different-types-clinical-research
https://www.nbcnews.com/health/mental-health/psilocybin-mushroom-help-people-alcohol-use-disorder-rcna44180
https://www.wsj.com/articles/psychedelic-compound-in-magic-mushrooms-shows-new-promise-as-alcohol-addiction-treatment-11661354909
){kind=link}
Comments
Comments are disabled for this post.